Chinese english Germany Japanese Korea

ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate

ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate Struktur
587009-71-0
CAS-Nr.
587009-71-0
Englisch Name:
ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate
Synonyma:
ethyl 4-[4-(4-fluorophenyl)-3-methyl-6-oxo-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]benzoate;ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate;Benzoic acid, 4-[4-(4-fluorophenyl)-4,6-dihydro-3-methyl-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]-, ethyl ester
CBNumber:
CB94017489
Summenformel:
C21H18FN3O3
Molgewicht:
379.38
MOL-Datei:
587009-71-0.mol
Request For Quotation

ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate Eigenschaften

Sicherheit

ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate Chemische Eigenschaften,Einsatz,Produktion Methoden

ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6349 50
VITAS-M LABORATORY, LTD. --
 Russia 6753 64
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6176 60
Specs --
 info@specs.net The Netherlands 6833 70
  • ethyl 4-(4-(4-fluorophenyl)-3-methyl-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate
  • ethyl 4-[4-(4-fluorophenyl)-3-methyl-6-oxo-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]benzoate
  • Benzoic acid, 4-[4-(4-fluorophenyl)-4,6-dihydro-3-methyl-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]-, ethyl ester
  • 587009-71-0
Copyright 2019 © ChemicalBook. All rights reserved